- Datum01.04.2024
- Uhrzeit19:00 - 20:00 Uhr
- VeranstalterBNP Paribas
Du willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnenEnanta Pharmaceuticals Inc. Kurse
Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
---|---|---|---|---|---|---|
VK | ||||||
VK | ||||||
VK |
Passende Produkte
WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
---|
Wertentwicklung (Nasdaq)
Wikifolio
Passender Service zu Enanta Pharmaceuticals Inc.
Webinar zu Enanta Pharmaceuticals Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)8,080-41,450
- Jahrestief / Hoch ($)9,240-17,760
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Enanta Pharmaceuticals Inc.
Termine von Enanta Pharmaceuticals Inc.
- Mai6Enanta Pharmaceuticals Inc.Q2 2024 Earnings Release
- Aug6Enanta Pharmaceuticals Inc.Q3 2024 Earnings Release
- Nov18Enanta Pharmaceuticals Inc.Q4 2024 Earnings Release
Beschreibung
Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
Pivot-Points (Nasdaq)
- Pivot-HBOP - R3-
- Pivot-Resist - R2-
- Pivot-High - R1-
- Pivotpunkt-
- Pivot-Low - S1-
- Pivot-Support - S2-
- Pivot-LBOP - S3-